HDAC4 and cancer: LMK-235, a novel HDAC class IIA HDACi specifically inhibiting HDAC5 (IC50 = 4.22 nM) and HDAC4 (IC50 = 11.9 nM), was found to be cytotoxic in several human cancer cell lines [31].